Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy

by Barnstorf-Brandes, J., Baurmann, H., Blasczyk, R., Bonifacius, A., Brauns, O., Clark, C., Cornely, O.A, Eiz-Vesper, B., Gödecke, N., Goudeva, L., Hallek, M., Koch, S., Köhler, P., Lang, P., Maecker-Kolhoff, B., Martens, J., Mausberg, P., Santamorena, M.M, Schenk, J., Seiferling, D., Simon, M., Tischer-Zimmermann, S., Verboom, M., Wittig, J.
Published 2022